A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment (NCT06110494) | Clinical Trial Compass
CompletedPhase 4
A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment
United States44 participantsStarted 2020-07-13
Plain-language summary
The goal of this observational is study is to develop a protocol for root canal biofilms disinfection using a clinically approved and commercially available iron oxide nanoparticle formulation Ferumoxytol/H2O2 treatments. This protocol will be testing local single topical application of Ferumoxytol within the root canal system in patients going through routine root canal treatment, evaluate its potential as anti-biofilm treatment and compare it to the clinical gold standard disinfecting solution sodium hypochlorite (positive control) and saline (negative control).
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Patients to welling to participate in the study.
✓. Patients are 18 years or above.
✓. Non-contributory medical history (Patient can be seen for regular dental appointment in PDM; ASA classes I and II).
✓. Tooth requiring root canal treatment with radiographic presence of periapical radiolucency and responding to thermal sensitivity testing negatively (difluordichlormethane at 50 °C) (Endo-Ice, Coltène/Whaledent Inc., Cuyahoga Falls, Ohio) and Negatively to EPT testing.
✓. Tooth with adequate remaining tooth structure for proper isolation with rubber dam.
✓. No history of previous endodontic treatment on the tooth.
✓. Teeth with single canal and single and roots with single canals in multirooted teeth.
Exclusion criteria
✕. Self-reported Pregnancy.
✕. Patients requiring antibiotic premedication prior to dental treatment.
What they're measuring
1
The Primary Outcome Parameter Will be the Difference in Bacterial Reduction Between the Experimental and Control Disinfection Groups Group (Ferumoxytol) and Comparison Groups (Positive and Negative Controls).
Timeframe: baseline (pretreatment) and after 10 minutes of treatment (post treatment)